Related Experiment Video
Updated: Aug 7, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Antibiotic Therapy for the Prevention and Treatment of Neonatal Sepsis
Sarah A Coggins1, Karen M Puopolo1
1Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, University of Pennsylvania, Philadelphia, PA, USA.
Insights
Antibiotics are frequently used in neonatal intensive care units for infections like sepsis. This review covers neonatal antimicrobial pharmacology and drug data to guide treatment decisions for vulnerable infants.
Area of Science:
- Neonatal pharmacology
- Infectious disease in neonates
- Antimicrobial stewardship
Background:
- Antibiotics are widely used in neonatal intensive care units (NICUs) for preterm and term infants.
- Infants may be exposed to antibiotics prenatally, at birth, or during NICU stays for suspected early- or late-onset sepsis.
- Antibiotic selection is complex, requiring consideration of infection timing, microbiology, patient factors, and resistance patterns.
Purpose of the Study:
- To summarize fundamental concepts of neonatal antimicrobial pharmacology.
- To present available neonatal-specific pharmacokinetic/pharmacodynamic (PK/PD) data for common antibiotics.
Main Methods:
- Review of existing literature on neonatal antibiotic use.
- Compilation of PK/PD data for frequently prescribed antimicrobial agents in neonates.
Main Results:
- Discussion of key principles governing antibiotic behavior in neonates.
- Presentation of PK/PD profiles for commonly used antibiotics, highlighting differences from adult data.
Conclusions:
- Optimizing antibiotic therapy in neonates requires understanding their unique pharmacology.
- Neonatal-specific PK/PD data are crucial for effective and safe antimicrobial treatment, guiding appropriate dosing and selection.
Abstract:
Antibiotics are among the most commonly prescribed medications in neonatal intensive care units. Preterm and term infants are commonly exposed to antibiotics: before birth via transplacental intrapartum maternal exposures, at birth due to suspected early-onset sepsis, or due to suspected late-onset sepsis in the first weeks to months of a neonatal intensive care unit hospitalization. Antibiotic selection requires assessment of infection timing and associated microbiology patterns, patient-specific factors (eg, colonization status, source of infection), and antibiotic resistance concerns. In this article, we summarize basic concepts relevant to neonatal antimicrobial pharmacology and available neonatal-specific pharmacokinetic/pharmacodynamic data for commonly-used antibiotic agents.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Microbiota Modulation by Antibiotics
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies II: Urine Culture and Sensitivity Test
